Benign Prostatic Hyperplasia: Test and Diagnosis

The diagnosis of benign prostatic hypertrophy (BPH) is made on the basis of the clinical picture and the results of medical device diagnostics.2nd-order laboratory parameters-depending on the results of the history, physical examination, and medical device diagnostics-are used for differential diagnostic clarification

PSA levels and screening intervals [S2e guideline].

  • Screening examination to exclude prostate cancer: annually from the age of 40.
  • In case of low PSA (< 2 ng/ml) and non-suspicious digital-rectal examination (DRU).
    • < 1 ng/ml every 4 years
    • 1-2 ng/ml every 2 years
    • Men > 70 years and PSA level < 1 ng/ml: no further PSA-based screening recommended.